Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Olivia Lum: President of Hyflux, leading water and environmental solutions company based in Singapore.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Olivia Lum is Chairman/CEO at Hyflux Ltd.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Unlocking the Potential of Medicinal Cannabis: Innovations in Therapeutic Solutions | Mark Lucas, CEO, Cannasouth Ltd.
00:10:00
led investment rounds for legal AI platform Harvey and online mental health platform Grow Therapy|Pat Grady,partner,Sequoia
00:10:00
backing global entrepreneurs in the field of information technology|Eduardo Saverin,Co-Founder and Partner,B Capital Group
00:10:00
Dr. Axel Kaufmann, Board Member and CFOO of Nemetschek SE, delivers an elevator pitch, while Ronald Slabke, CEO of Hypoport SE, provides a testimonial.
00:10:00
High-Speed Data in Non-Terrestrial Applications | Richard Gibbs , Chief Executive Officer of Filtronic Plc
00:00:00
Redx Pharma begins testing lead drug in phase II trial for idiopathic pulmonary fibrosis - Lisa Anson Chief Executive Officer, Redx Pharma
00:10:00
Key Insights on Real-Time Data and Water Management from Industry Professionals
00:10:00
RNC Minerals Highlights Strong Growth and Strategic Developments at One-to-One Mining Investment Conference
00:10:00
Nick Dell'Osso, CEO of Chesapeake Energy, discusses the implications of plunging natural gas prices for 2023 on 'Squawk Box'.
00:10:00
Strategies for Navigating Financial Markets Amidst Uncertainty | Katie Koch, CEO , TCW Group.
00:10:00
Red Paramount Iron CEO Discusses Green Iron Production and Community Engagement
00:10:00
PetVivo's Innovative OsteoCushion Targets Root Cause of Osteoarthritis in Pets, Promises Major Market Potential|John Lai,CEO,PetVivo Holdings Inc